UAE mandates 5-year jail and AED 50,000 fine for pharmacy drug offences

Federal legislation mandates a minimum five-year prison sentence and a fine of at least AED 50,000 for pharmaceutical facilities found in violation of controlled substance regulations. The law requires stricter oversight for the storage, distribution, and record-keeping of restricted medications across the UAE.

Pharmacy owners and operations managers face immediate liability shifts under these provisions. Audit protocols for tracking psychotropic and narcotic drugs require review to avoid penalties. Failure to report inventory discrepancies or deviations from Ministry of Health and Prevention (MOHAP) dispensing guidelines exposes the licensee to immediate prosecution.

Medical directors must cross-reference their electronic health records with federal drug tracking databases to confirm data integrity. The legislation treats improper documentation of controlled substances with the same legal gravity as illicit trafficking. Facilities using manual logging systems face the highest risk of non-compliance.

CFOs should adjust legal reserves as regulatory scrutiny intensifies. Operators failing to implement automated, track-and-trace systems for pharmacy stock may face increased insurance premiums or the revocation of dispensing licenses by MOHAP, the Dubai Health Authority, or the Department of Health – Abu Dhabi.